Nutrex Research

Lipo 6X Advanced Formula

D
N+ Score62
Pre-WorkoutServing: 1 Capsule(s)Type: Other Combinations

Nutrex Research Lipo 6X Advanced Formula is a pre-workout and 'Other Combinations' supplement containing 6 ingredients, designed for those seeking energy and metabolic support. Key ingredients include 200 mg of Caffeine Anhydrous, 20 mg of Synephrine HCl, and 3 mg of Yohimbine HCl, which are commonly used for their stimulant properties and potential to support energy levels. However, based on available data, none of the listed ingredients are present at dosages considered clinically studied for their respective effects in this formulation. With an N+ Score of 62 and a 'D' grade, this product is rated as average, showing 100% label transparency but lower ingredient adequacy (50%) and formula completeness (33%). This supplement may appeal to individuals looking for a stimulant-based pre-workout, but should be noted for its lack of clinically dosed ingredients.

About This Product

Lipo 6X Advanced Formula by Nutrex Research is a pre-workout supplement containing 6 active ingredients. It has earned an N+ Score of 62/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness33/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity83/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (6 ingredients)

IngredientAmountDose Adequacy
Caffeine Anhydrous200.000 mgN/A
Yohimbine HCl3.000 mgN/A
Synephrine HCl20.000 mgN/A
Synthetic Acacia rigidula Mimicking Complex100.000 mgN/A
Synthetic Guggulsterones Z&E 1:120.000 mgN/A
Phase #1 Rapid Release Liquid Delivery Blend806.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.